Arcus Biosciences (RCUS) Current Taxes (2021 - 2022)

Arcus Biosciences (RCUS) recorded quarterly Current Taxes of $18000.0 in Q3 2022, little changed quarter-over-quarter from $18000.0 in Q2 2022.

Arcus Biosciences (RCUS) Current Taxes (2021 - 2022) Analysis & Trends

Arcus Biosciences' Current Taxes history runs 2 years deep, the most recent figure standing at $18000.0 for Q3 2022.

In Q3 2022, Current Taxes changed N/A year-over-year to $18000.0; the TTM figure through Sep 2022 stood at $18000.0 (changed N/A YoY), while the FY2021 annual figure was $2.0 million, changed N/A from the prior year.
Current Taxes was $18000.0 for Q3 2022 at Arcus Biosciences, roughly flat from $18000.0 in the prior quarter.
In the past five years, Current Taxes ranged from a high of $2.8 million in Q1 2022 to a low of $18000.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	10,460.56
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	19.20 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Arcus Biosciences	3.05 Bn	2.23 Bn	-	-

Download Data